Pfizer is licensing a promising investigational cancer medicine from a smaller company. This move improves the drugmaker's ...

Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest polyolefins producer in the Americas, as well as ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

TeamSense ranked all 50 states and the District of Columbia by their level of search interest in manufacturing topics.

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

BEL, DLF, PI Inds, Petronet LNG, NLC India, Gujarat Gas, IRB Infrastructure, New India Assurance, Power Grid, Redington, Pfizer, Karur Vysya Bank, Jupiter Wagons, DOMS Inds, Acme Solar, GMR Power, CMS ...

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, ...

The HHS leader has a different view of health and wellness, and that's teasing out some tantalizing opportunities for ...